Both in Biotechnology
Tevogen vs Voyager Therapeutics
Over the past year TVGN returned −79.7% and VYGR returned −60.2%; their daily moves had a correlation of -0.02.
TVGN −79.7% VYGR −60.2%Growth of $1, one year, split-adjusted
| Metric | TVGN | VYGR |
|---|---|---|
| Price | $5.97 | $1.83 |
| Market cap | $93.9M | $112.5M |
| Today | +6.80% | +2.53% |
| 1 month | −9.5% | −25.8% |
| 6 months | −19.0% | −53.2% |
| Year to date | −63.9% | −53.6% |
| 1 year | — | −60.9% |
| Revenue growth (YoY) | — | −39.1% |
| Gross margin | — | 100.0% |
| Net margin | — | −773.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.3× |
| Net cash | -$7.0M | $116.3M |
| Dividend yield | — | — |
| Volatility (60d) | 60.9% | 60.8% |
| Short % of float | 3.9% | 7.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).